{"DataElement":{"publicId":"7206464","version":"1","preferredName":"Gemtuzumab Ozogamicin Planned Dose Administered Known Unknown Indicator","preferredDefinition":"The indicator that describes if the planned dose of gemtuzumab ozogamicin administered was known or unknown.","longName":"7206463v1.0:2935542v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7206463","version":"1","preferredName":"Gemtuzumab Ozogamicin Dose Administered","preferredDefinition":"A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin.  In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. (NCI04)_The act of having given something (e.g., a medication or test)._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","longName":"7267616v1.0:2233610v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"7267616","version":"1","preferredName":"Gemtuzumab Ozogamicin Dose","preferredDefinition":"A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin.  In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. (NCI04):A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","longName":"C1806:C25488","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gemtuzumab Ozogamicin","conceptCode":"C1806","definition":"A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin.  In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4846F2A-A623-4A60-E053-F662850AE1BF","latestVersionIndicator":"Yes","beginDate":"2020-04-30","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-04-30","modifiedBy":"ONEDATA","dateModified":"2020-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A10F19B8-035C-6823-E053-F662850AA9ED","latestVersionIndicator":"Yes","beginDate":"2020-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-03-17","modifiedBy":"KUMMEROA","dateModified":"2020-12-21","changeDescription":". 2020-12-21 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2935542","version":"1","preferredName":"Known Unknown Indicator","preferredDefinition":"Recognized, familiar, or within the scope of knowledge._Not known, not observed, not recorded, or refused._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"2935542v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Known","valueDescription":"Known","ValueMeaning":{"publicId":"2934435","version":"1","preferredName":"Known","longName":"2934435","preferredDefinition":"Recognized, familiar, or within the scope of knowledge.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Known","conceptCode":"C80137","definition":"Recognized, familiar, or within the scope of knowledge.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7181A67F-9F52-BB55-E040-BB89AD432FA8","latestVersionIndicator":"Yes","beginDate":"2009-08-19","endDate":null,"createdBy":"SCOTTLO","dateCreated":"2009-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BF55B58-25B1-A4FE-E040-BB89AD436660","beginDate":"2009-08-25","endDate":null,"createdBy":"WHITES","dateCreated":"2009-12-30","modifiedBy":"ONEDATA","dateModified":"2009-12-30","deletedIndicator":"No"},{"value":"Not known","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BF55B58-25C5-A4FE-E040-BB89AD436660","beginDate":"2009-08-25","endDate":"2013-09-04","createdBy":"WHITES","dateCreated":"2009-12-30","modifiedBy":"KUMMEROA","dateModified":"2013-09-04","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E58FF59D-26B2-0DD0-E040-BB89AD4320D4","beginDate":"2013-09-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-09-04","modifiedBy":"ONEDATA","dateModified":"2013-09-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2935541","version":"1","preferredName":"Known Unknown Indicator","preferredDefinition":"Recognized, familiar, or within the scope of knowledge.:Not known, not observed, not recorded, or refused.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C80137:C17998:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Known","conceptCode":"C80137","definition":"Recognized, familiar, or within the scope of knowledge.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F8C85B-6EE5-9265-E040-BB89AD433FDD","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-08-25","modifiedBy":"ONEDATA","dateModified":"2009-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F8C85B-6EF6-9265-E040-BB89AD433FDD","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-08-25","modifiedBy":"KUMMEROA","dateModified":"2013-12-13","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Was the planned dose of gemtu","type":"Preferred Question Text","description":"Was the planned dose of gemtuzumab ozogamicin administered known or unknown?","url":null,"context":"NHLBI"},{"name":"Prescribed dose","type":"Application Standard Question Text","description":"Prescribed dose","url":null,"context":"NHLBI"},{"name":"Prescribed dose of gemtuzumab ozogamicin","type":"Alternate Question Text","description":"Prescribed dose of gemtuzumab ozogamicin","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A10F2825-8065-3B1D-E053-F662850A16F2","latestVersionIndicator":"Yes","beginDate":"2020-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-03-17","modifiedBy":"KUMMEROA","dateModified":"2021-06-02","changeDescription":"2021-6-2 ak OK to release per WZ. System generated def displayed as alt def. Added AQT. 04/07/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}